Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
MDX-124
i
Other names:
MDX-124
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(2)
News
Trials
Company:
Medannex
Drug class:
Annexin A1 inhibitor
‹
›
Associations
(2)
News
Trials
VERI cancer hierarchy
Reset Filters
ANXA1 overexpression
Acute Myelogenous Leukemia
ANXA1 overexpression
Acute Myelogenous Leukemia
MDX-124
Sensitive: D – Preclinical
MDX-124
Sensitive
:
D
MDX-124
Sensitive: D – Preclinical
MDX-124
Sensitive
:
D
ANXA1 overexpression
Triple Negative Breast Cancer
ANXA1 overexpression
Triple Negative Breast Cancer
MDX-124
Sensitive: D – Preclinical
MDX-124
Sensitive
:
D
MDX-124
Sensitive: D – Preclinical
MDX-124
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login